01 2EMD Serono
02 10EMD Serono, A Division of EMD Inc., Canada
01 42399100
02 32518903
03 12526099
04 42700662
01 11FOLLITROPIN ALFA | LUTROPIN ALFA
02 1LUTROPIN ALFA
01 2POWDER FOR SOLUTION
02 10SOLUTION
01 42021-01-22
02 32024-04-02
03 12024-06-16
04 42028-10-29
Patent Expiration Date : 2024-06-16
Date Granted : 2013-02-05
FOLLITROPIN ALFA, LUTROPIN ALFA
Brand Name : PERGOVERIS
Patent Number : 2526099
Filing Date : 2004-06-16
Strength per Unit : 150 IU / 75 IU
Dosage Form : POWDER FOR SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2024-06-16
Date Granted : 2013-02-05
Patent Expiration Date : 2021-01-22
Date Granted : 2011-11-08
FOLLITROPIN ALFA, LUTROPIN ALFA
Brand Name : PERGOVERIS
Patent Number : 2399100
Filing Date : 2001-01-22
Strength per Unit : 150 IU / 75 IU
Dosage Form : POWDER FOR SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2021-01-22
Date Granted : 2011-11-08
Patent Expiration Date : 2028-10-29
Date Granted : 2015-10-13
Brand Name : LUVERIS
Patent Number : 2700662
Filing Date : 2008-10-29
Strength per Unit : 450 IU / 0.72 mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2028-10-29
Date Granted : 2015-10-13
Patent Expiration Date : 2024-04-02
Date Granted : 2013-02-05
FOLLITROPIN ALFA, LUTROPIN ALFA
Brand Name : PERGOVERIS
Patent Number : 2518903
Filing Date : 2004-04-02
Strength per Unit : 300 IU / 150 IU per pen
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2024-04-02
Date Granted : 2013-02-05
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2028-10-29
Date Granted : 2015-10-13
FOLLITROPIN ALFA, LUTROPIN ALFA
Brand Name : PERGOVERIS
Patent Number : 2700662
Filing Date : 2008-10-29
Strength per Unit : 300 IU / 150 IU per pen
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2028-10-29
Date Granted : 2015-10-13
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2021-01-22
Date Granted : 2011-11-08
FOLLITROPIN ALFA, LUTROPIN ALFA
Brand Name : PERGOVERIS
Patent Number : 2399100
Filing Date : 2001-01-22
Strength per Unit : 300 IU / 150 IU per pen
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2021-01-22
Date Granted : 2011-11-08
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2024-04-02
Date Granted : 2013-02-05
FOLLITROPIN ALFA, LUTROPIN ALFA
Brand Name : PERGOVERIS
Patent Number : 2518903
Filing Date : 2004-04-02
Strength per Unit : 450 IU / 225 IU per pen
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2024-04-02
Date Granted : 2013-02-05
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2028-10-29
Date Granted : 2015-10-13
FOLLITROPIN ALFA, LUTROPIN ALFA
Brand Name : PERGOVERIS
Patent Number : 2700662
Filing Date : 2008-10-29
Strength per Unit : 450 IU / 225 IU per pen
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2028-10-29
Date Granted : 2015-10-13
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2021-01-22
Date Granted : 2011-11-08
FOLLITROPIN ALFA, LUTROPIN ALFA
Brand Name : PERGOVERIS
Patent Number : 2399100
Filing Date : 2001-01-22
Strength per Unit : 450 IU / 225 IU per pen
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2021-01-22
Date Granted : 2011-11-08
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2024-04-02
Date Granted : 2013-02-05
FOLLITROPIN ALFA, LUTROPIN ALFA
Brand Name : PERGOVERIS
Patent Number : 2518903
Filing Date : 2004-04-02
Strength per Unit : 900 IU / 450 IU per pen
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2024-04-02
Date Granted : 2013-02-05
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
